Bressman, S.(Susan Bressman)
patient mutation lrrk 2 2019ser disease idiopathic pd parkinson symptom idiopathic study lrrk 2-associated pd neurology onset centre frequency university carrier family department estimate research penetrance consortium stage qsbb series lrrk 2 mutations series group hospital institute 10 years ﬀerence scale london analysis prevalence 79 years disorder parkinsonism ﬀected grant 2-associated method cause treatment population tremor article pd onset 69 years duration testing disease duration di ﬀerence dystonia health progression incidence symptom onset control individual genetic table non-motor symptoms foundation state 40 years 59 years penetrance estimates clinic kaplan-meier hoehn sample medicine university college london qsbb group queen square park 2 mutations york state department ﬁ ve patients
1 Most Recent Publications
Phenotype, genotype, and worldwide genetic penetrance of LRRK2-associated Parkinson's disease: a case-control study
Healy, D.G. Falchi, M. Ferreira, J.J. Tolosa, E. Kay, D.M. Klein, C. Williams, D.R. Marras, C. Lang, A.E. Wszolek, Z.K. Berciano, J. Schapira, A.H. O'Sullivan, S.S. Lynch, T. Bhatia, K.P. Gasser, T. Lees, A.J. Wood, N.W. Bonifati, V. Durr, A. Bressman, S. Brice, A. Aasly, J. Zabetian, C.P. Goldwurm, S.